Probiotics for Clostridium difficile-associated diarrhea: focus on Lactobacillus rhamnosus GG and Saccharomyces boulardii (Q36862309)

16 August 2017

1 reference

title

Probiotics for Clostridium difficile-associated diarrhea: focus on Lactobacillus rhamnosus GG and Saccharomyces boulardii (English)

1 reference

16 August 2017

0 references

0 references

Clostridium difficile

0 references

Saccharomyces boulardii

object named as

Saccharomyces boulardii

1 reference

based on heuristic

inferred from title

Lactobacillus rhamnosus

object named as

Lactobacillus rhamnosus

1 reference

based on heuristic

inferred from title

author name string

Marisel Segarra-Newnham

series ordinal

1

1 reference

PubMed ID

17595306

16 August 2017

language of work or name

English

0 references

publication date

26 June 2007

1 reference

Annals of Pharmacotherapy

16 August 2017

1 reference

16 August 2017

41

1 reference

16 August 2017

7

1 reference

16 August 2017

1212-1221

1 reference

Clinical manifestations, treatment and control of infections caused by Clostridium difficile.

16 August 2017

1 reference

Treatment of Clostridium difficile-associated disease: old therapies and new strategies

21 January 2018

1 reference

Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea

21 January 2018

1 reference

Epidemiology of Clostridium difficile infection in a large population of hospitalized US military veterans

21 January 2018

1 reference

Narrative review: the new epidemic of Clostridium difficile-associated enteric disease

21 January 2018

1 reference

Epidemiology, risk factors and treatments for antibiotic-associated diarrhea.

21 January 2018

1 reference

Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile diarrhea

21 January 2018

1 reference

Probiotics in the prevention and treatment of gastrointestinal infections

21 January 2018

1 reference

Alternative treatments for Clostridium difficile disease: what really works?

21 January 2018

1 reference

Recurrent Clostridium difficile diarrhoea

21 January 2018

1 reference

Past, present, and future therapies for Clostridium difficile-associated disease

21 January 2018

1 reference

Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections

21 January 2018

1 reference

Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial

21 January 2018

1 reference

Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases.

21 January 2018

1 reference

Probiotic agents and infectious diseases: a modern perspective on a traditional therapy

21 January 2018

1 reference

Lactobacillus sepsis associated with probiotic therapy

21 January 2018

1 reference

Lactobacillus bacteremia and endocarditis: review of 45 cases

21 January 2018

1 reference

Lactobacillus sepsis associated with probiotic therapy.

21 January 2018

1 reference

Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG

21 January 2018

1 reference

Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland

21 January 2018

1 reference

A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease

21 January 2018

1 reference

Fatal Saccharomyces cerevisiae aortic graft infection

21 January 2018

1 reference

Saccharomyces cerevisiae fungemia: an adverse effect of Saccharomyces boulardii probiotic administration

21 January 2018

1 reference

Saccharomyces cerevisiae fungemia: an emerging infectious disease

21 January 2018

1 reference

Outbreak of Saccharomyces cerevisiae Subtype boulardii Fungemia in Patients Neighboring Those Treated with a Probiotic Preparation of the Organism

21 January 2018

1 reference

Possible role of catheters in Saccharomyces boulardii fungemia

21 January 2018

1 reference

Seven cases of fungemia with Saccharomyces boulardii in critically ill patients.

21 January 2018

1 reference

Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii.

21 January 2018

1 reference

Fungemia with Saccharomyces cerevisiae in two newborns, only one of whom had been treated with ultra-levura

21 January 2018

1 reference

Methaemoglobinaemia with concurrent blood isolation of Saccharomyces and Candida

21 January 2018

1 reference

Saccharomyces cerevisiae fungemia in a head and neck cancer patient: a case report and review of the literature

21 January 2018

1 reference

Saccharomyces cerevisiae fungemia in an elderly patient with Clostridium difficile colitis

21 January 2018

1 reference

Saccharomyces boulardii induced sepsis: successful therapy with voriconazole after treatment failure with fluconazole

21 January 2018

1 reference

Invasive Saccharomyces infection: a comprehensive review

21 January 2018

1 reference

Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea.

21 January 2018

1 reference

Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis

21 January 2018

1 reference

Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1K110

1 reference

16 August 2017

1 reference

PubMed ID

17595306